SOUTHFIELD, Mich., Nov. 27 /PRNewswire/ -- CIG Corp. (CIG) previously named Capital Investment Group announces the creation of a medical advisory board made up of highly-skilled, prominent physicians from around the country and worldwide.
CIG has a niche in the medical industry and continues to expand its involvement in this arena. The Medical Advisory Board will support CIG in its effort to review investment opportunities in the health care and medical fields.
"CIG is experiencing great success in the area of Asset Management and specifically in Product Structuring. Several investment opportunities in the medical/healthcare field are presented to CIG regularly for consulting and product structuring review," said Bassem Saad, CIG's Director of Asset Management. Saad continued, "CIG is required to review these investment opportunities based on their practical application in the marketplace, the value proposition, financial pro-forma, and the overall business plan. In doing so, CIG then raises private equity to fund the investment opportunity to make it operational. The primary focus for CIG is to determine if the investment opportunity represents a good investment vehicle for its clients."
The Advisory Board is composed of experts in the field of medicine who
are willing to share their time and knowledge by critiquing and offering
expertise to CIG's product offerings. The Advisory Board members are
responsible for bringing relevant industry issues to CIG's attention and
The medical board consists of:
Sunil Bhatia, M.D.
Michael Diamond, M.D.
R. Ralph Margulis, M.D.
Adnan Munkarah, M.D.
Philip Philip, M.D., PhD
Mike Royal, M.D., J.D., M.B.A.
Dr. Sunil Bhatia began his clinical cardiology practice in 1982 and joined Michigan Heart in 1990. He is past Chief of the Medical Staff and Director of the Specialty Care Unit at Beyer Hospital. Dr. Bhatia is an adjunct Clinical Instructor at the University of Michigan. He is board certified in Internal Medicine and Cardiology. Dr. Bhatia has served on the Board of the Oakwood Health System and was chairman of its Council of Chiefs as well. Dr. Bhatia attended the Prince of Wales Medical School in Patna, India.
Dr. Michael Diamond is the Associate Chairman, Department of Obstetrics and Gynecology, School of Medicine at Wayne State University in Detroit, Michigan. Dr. Diamond was Vice Chairman for Research, Department of Obstetrics and Gynecology for the Detroit Medical Center. Dr. Diamond is board certified in Obstetrics and Gynecology and has won several top doctor awards including, "Top Obstetricians and Gynecologists", Consumer's Research Council of America, 2007. Dr. Diamond has a B.A. in Biochemistry at Vassar College in Poughkeepsie, New York and a medical degree from Vanderbilt University Medical School in Nashville, Tennessee.
Dr. Ralph Margulis, Sr. is the current Executive Vice President of Strategic Planning for United Physicians. He is also a past President and Chairman of the Board for the corporation. Dr. Margulis has served in several capacities at William Beaumont Hospital-Royal Oak i.e. Member-at-Large, Medical Executive Board; Associate Medical Director; and Associate Medical Director of Clinical Affairs. Dr. Margulis received his undergraduate degree from the University of Belgrade, Yugoslavia and his Medical degree from Harvard Medical School. He is a Diplomate, American Board of Internal Medicine; Fellow, American College of Physicians and a Diplomate, American Board of Managed Care Medicine.
Dr. Adnan Munkarah, a board certified Obstetrician-Gynecologist, is a clinical professor of Obstetrics and Gynecology at Wayne State University in Michigan. Two years ago, he was recruited to head and rebuild the department of Obstetrics and Gynecology at the King Faisal Specialist Hospital in Saudi Arabia, one of the largest tertiary care centers in the Middle East region. Dr. Munkarah pursued his postgraduate training in Internal Medicine and Obstetrics and Gynecology at Wayne State University. He subsequently completed a fellowship in Gynecologic Oncology at MD Anderson Cancer Center in Texas.
Dr. Philip Philip is a tenured Professor in Medicine and Oncology, Karmanos Cancer Institute, NCI-designated Comprehensive Cancer Center, Wayne State University, School of Medicine, Department of Internal Medicine, Division of Hematology/Oncology, Detroit, Michigan. Dr. Philip is also an attending physician in Hematology/Oncology at the Karmanos Cancer Center and heads the Center's Gastrointestinal Cancer Program. Dr. Philip also chairs the Protocol Review and Monitoring Committee at the Karmanos Cancer Institute. He is board certified in internal medicine and oncology and is also a fellow of the Royal College of Physicians in the United Kingdom.
Dr. Mike Royal has served as Vice President, Clinical Development- Analgesics, Cadence Pharmaceuticals. Dr. Royal has owned and managed the largest private practice pain management clinic and research center in Oklahoma. Dr. Royal is board certified in internal medicine, anesthesiology, pain management, and addiction medicine and has published extensively in the area of pain management. He holds a B.S. in chemistry from the Massachusetts Institute of Technology, an M.D. from the University of Massachusetts, a J.D. from the University of Maryland and an M.B.A. from New York University (TRIUM).
For more information on the medical board or for their detailed biographies, go to http://www.cigcorporation.com and click on press release.
CIG Corp. is a financial services boutique firm that offers
sophisticated financial solutions and consulting for individuals and
businesses. CIG offers its services through its wholly owned subsidiaries:
CIG Securities, Inc. is a broker dealer, Member FINRA/SIPC capable of
providing a wide range of securities transactions; CIG Risk Management,
Inc. is an insurance agency that provides life and disability insurance
products; CIG Asset Management, Inc. is a SEC Registered Investment Adviser
which provides business consulting, asset management, and structured asset
transactions; CIG Lending, Inc. provides brokered loans for residential and
commercial use. Please visit us at cigcorporation.com.
Contact: Dina Gustafson
Ph: (248) 827-1010
Securities Offered Through CIG Securities, Member FINRA/SIPC. Investment Advisory Services Available Through CIG Asset Management, Inc., a SEC Registered Investment Adviser. Insurance Services Provided by CIG Risk Management, Inc. Lending Activities Performed Through CIG Lending, Inc. All are Wholly Owned Subsidiaries of CIG Corp.
|SOURCE CIG Corp.|
Copyright©2007 PR Newswire.
All rights reserved